Blog

Blog

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

2016 has been a banner year for the healthcare and life sciences industries. This year we saw the launch of critical initiatives like the Vice President Biden’s Cancer Moonshot, aimed at improving our ability to prevent cancer and detect it an early stage. As recently as just this month, we saw the passing of the 21st Century Cures Act, an important step forward in transformation of our approach to precision health, in part by providing funding to some of our most promising research initiatives, setting us up to continue to achieve incredible milestones in 2017 and beyond. 

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

Thanks to recent moves by Congress last week, we’re one step closer to transforming the way in which we approach today’s sick care to true, precision healthcare. The 21st Century Cures Act – which includes funding for President Obama’s precision medicine initiative, the cancer “moonshot” effort and Alzheimer’s research – will promote high-risk, high-reward research using special procurement procedures, rather than through conventional grants and contracts, according to The New York Times. It’s a huge moment in history as these important initiatives receive the necessary funding for new research – and one that will bring us closer to preventing devastating diseases.

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

It is my pleasure to welcome you to the home of our new blog. We're particularly excited about launching this blog as it coincides with the re-launch of our Company’s website and new messaging focused on the science of precision health.

By Kevin Hrusovsky, CEO and Executive Chairman, Quanterix

In a world where the diagnostics tests we currently provide to patients are riddled with false positives and invasive procedures, it’s imperative that the best and brightest in their respected therapeutic fields have access to the most innovative and groundbreaking technology today. We’ve found that the collaboration of researchers and scientists across organizations play a vital role in the continued advancement of disease diagnostics and improved treatment options.

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

As individuals, we have the responsibility to challenge the norms of today to ensure that the generations of the future are able to live healthier, longer lives. Unfortunately, we are living in a world plagued by devastating diseases—the time to take action is now.